...
首页> 外文期刊>Indian Journal of Ophthalmology >Management of a rare presentation of Vogt-Koyanagi-Harada disease in human immunodeficiency virus/acquired immunodeficiency disease syndrome patient
【24h】

Management of a rare presentation of Vogt-Koyanagi-Harada disease in human immunodeficiency virus/acquired immunodeficiency disease syndrome patient

机译:管理人类免疫缺陷病毒/获得免疫缺陷症综合征患者Vogt-Koyanagi-Harada病的罕见展示

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Vogt-Koyanagi-Harada (VKH), a multisystem autoimmune bilateral panuveitis with systemic manifestations, is uncommon in immunocompromised patients such as human immunodeficiency virus (HIV)/acquired immunodeficiency disease syndrome (AIDS). We report a rare presentation of VKH in a 45-year-old HIV-positive female on highly active antiretroviral therapy (HAART) who presented with a history of recurrent panuveitis. A diagnosis of probable VKH was made based on ocular and systemic signs and symptoms. She was treated with topical and systemic steroids with close monitoring of CD4 counts and viral loads. After inflammation control, complicated cataract was managed surgically under perioperative steroid cover. VKH in HIV/AIDS has not been reported earlier. This case shows that significant inflammation can be seen even in HIV/AIDS patients on HAART with VKH in spite of moderate CD4 counts. Management is a challenge considering the systemic risks with long-term use of steroids.
机译:Vogt-Koyanagi-harada(VKH),一种具有全身性表现的多系统自身免疫性恐慌炎,在免疫缺陷患者(如人类免疫缺陷病毒(HIV)/获得的免疫缺陷症综合征(艾滋病)等免疫疗效中罕见。我们在高活性抗逆转录病毒治疗(HAART)举行了历史记录的血管炎历史上,举行了罕见的艾滋病毒阳性女性罕见展示VKH。基于眼部和全身性迹象和症状进行了可能的VKH的诊断。她被局部和全身类固醇治疗,密切监测CD4计数和病毒载量。在炎症治疗后,在围手术式类固醇覆盖下手术治疗复杂的白内障。艾滋病毒/艾滋病的VKH尚未提前报告。这种情况表明,即使在HAART在HAART的HIV /艾滋病患者中,仍然可以在VKH的艾滋病毒/艾滋病患者中可以看到显着的炎症,尽管是中等的CD4计数。管理是考虑到具有类固醇的长期使用的系统风险的挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号